Dennis Cindy-Lee, Dowswell Therese
University of Toronto and Women’s College Research Institute, Toronto, Canada.
Cochrane Database Syst Rev. 2013 Jul 31;2013(7):CD006795. doi: 10.1002/14651858.CD006795.pub3.
A meta-analysis of 21 studies suggests the mean prevalence rate for depression across the antenatal period is 10.7%, ranging from 7.4% in the first trimester to a high of 12.8% in the second trimester. Due to maternal treatment preferences and potential concerns about fetal and infant health outcomes, diverse non-pharmacological treatment options are needed.
To assess the effect of interventions other than pharmacological, psychosocial, or psychological interventions compared with usual antepartum care in the treatment of antenatal depression.
We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 January 2013), scanned secondary references and contacted experts in the field to identify other published or unpublished trials.
All published and unpublished randomised controlled trials of acceptable quality evaluating non-pharmacological/psychosocial/psychological interventions to treat antenatal depression.
Both review authors participated in the evaluation of methodological quality and data extraction. Results are presented using risk ratio (RR) for categorical data and mean difference (MD) for continuous data.
Six trials were included involving 402 women from the United States, Switzerland, and Taiwan. For most comparisons a single trial contributed data and there were few statistically significant differences between control and intervention groups.In a trial with 38 women maternal massage compared with non-specific acupuncture (control group) did not significantly decrease the number of women with clinical depression or depressive symptomatology immediately post-treatment (risk ratio (RR) 0.80, 95% confidence interval (CI) 0.25 to 2.53; mean difference (MD) -2.30, 95% CI -6.51 to 1.91 respectively). In another trial with 88 women there was no difference in treatment response or depression remission rates in women receiving maternal massage compared with those receiving non-specific acupuncture (RR 1.33, 95% CI 0.82 to 2.18; RR 1.14, 95% CI 0.59 to 2.19 respectively).In a trial with 35 women acupuncture specifically treating symptoms of depression, compared with non-specific acupuncture, did not significantly decrease the number of women with clinical depression or depressive symptomatology immediately post-treatment (RR 0.47, 95% CI 0.11 to 2.13; MD -3.00, 95% CI -8.10 to 2.10). However, women who received depression-specific acupuncture were more likely to respond to treatment compared with those receiving non-specific acupuncture (RR 1.68, 95% CI 1.06 to 2.66).In a trial with 149 women, maternal massage by a woman's significant other, compared with standard care, significantly decreased the number of women with depressive symptomatology immediately post-treatment (MD -6.70, 95% CI -9.77 to -3.63). Further, women receiving bright light therapy had a significantly greater change in their mean depression scores over the five weeks of treatment than those receiving a dim light placebo (one trial, n = 27; MD -4.80, 95% CI -8.39 to -1.21). However, they were not more likely to have a treatment response or experience a higher remission rate (RR 1.79, 95% CI 0.90 to 3.56; RR 1.89, 95% CI 0.81 to 4.42).Lastly, two trials examined the treatment effect of omega-3 oils. Women receiving omega-3 had a significantly lower mean depression score following eight weeks of treatment than those receiving a placebo (one trial, n = 33; MD -4.70, 95% CI -7.82 to -1.58). Conversely, in a smaller trial (21 women) there was no significant difference in the change in mean depression scores for women receiving omega-3 and those receiving a placebo (MD 0.36, 95% CI -0.17 to 0.89), and women who received omega-3 were no more likely to respond to treatment (RR 2.26, 95% CI 0.78 to 6.49) or have higher remission rates (RR 2.12, 95% CI 0.51 to 8.84). Women in the placebo group were just as likely to report a side effect as those in the omega-3 group (RR 1.12, 95% CI 0.56 to 2.27).
AUTHORS' CONCLUSIONS: The evidence is inconclusive to allow us to make any recommendations for depression-specific acupuncture, maternal massage, bright light therapy, and omega-3 fatty acids for the treatment of antenatal depression. The included trials were too small with non-generalisable samples, to make any recommendations.
一项对21项研究的荟萃分析表明,孕期抑郁症的平均患病率为10.7%,其中孕早期为7.4%,孕中期高达12.8%。由于产妇的治疗偏好以及对胎儿和婴儿健康结果的潜在担忧,需要多种非药物治疗选择。
评估与常规产前护理相比,非药物、心理社会或心理干预措施在治疗产前抑郁症中的效果。
我们检索了Cochrane妊娠与分娩组试验注册库(2013年1月31日),查阅了二次参考文献,并联系了该领域的专家以识别其他已发表或未发表的试验。
所有已发表和未发表的、质量可接受的随机对照试验,评估用于治疗产前抑郁症的非药物/心理社会/心理干预措施。
两位综述作者参与了方法学质量评估和数据提取。分类数据的结果采用风险比(RR)呈现,连续数据的结果采用均数差(MD)呈现。
纳入了6项试验,涉及来自美国、瑞士和台湾的402名女性。对于大多数比较,单个试验提供了数据,对照组和干预组之间几乎没有统计学上的显著差异。
在一项有38名女性的试验中,与非特异性针灸(对照组)相比,产妇按摩在治疗后即刻并未显著减少有临床抑郁症或抑郁症状的女性数量(风险比(RR)0.80,95%置信区间(CI)0.25至2.53;均数差(MD) -2.30,95% CI -6.51至1.91)。在另一项有88名女性的试验中,接受产妇按摩的女性与接受非特异性针灸的女性相比,治疗反应或抑郁缓解率没有差异(RR 1.33,95% CI 0.82至2.18;RR 1.14,95% CI 0.59至2.19)。
在一项有35名女性的试验中,专门治疗抑郁症状的针灸与非特异性针灸相比,在治疗后即刻并未显著减少有临床抑郁症或抑郁症状的女性数量(RR 0.47,95% CI 0.11至2.13;MD -3.00,95% CI -8.10至2.10)。然而,与接受非特异性针灸的女性相比,接受专门治疗抑郁的针灸的女性对治疗的反应更有可能(RR 1.68,95% CI 1.06至2.66)。
在一项有149名女性的试验中,与标准护理相比,女性的重要他人进行的产妇按摩在治疗后即刻显著减少了有抑郁症状的女性数量(MD -6.70,95% CI -9.77至 -3.63)。此外,在为期五周的治疗中,接受强光疗法的女性平均抑郁评分的变化显著大于接受暗光安慰剂的女性(一项试验,n = 27;MD -4.80,95% CI -8.39至 -1.21)。然而,她们对治疗有反应或缓解率更高的可能性并不更大(RR 1.79,95% CI 0.90至3.56;RR 1.89,95% CI 0.81至4.42)。
最后,两项试验研究了ω-3油的治疗效果。接受ω-3治疗八周后的女性平均抑郁评分显著低于接受安慰剂的女性(一项试验,n = 33;MD -4.70,95% CI -7.82至 -1.58)。相反,在一项较小的试验(21名女性)中,接受ω-3和接受安慰剂的女性平均抑郁评分变化没有显著差异(MD 0.36,95% CI -0.17至0.89),接受ω-3的女性对治疗有反应或缓解率更高的可能性并不更大(RR 2.26,95% CI 0.78至6.49;RR 2.12,95% CI 0.51至8.84)。安慰剂组女性报告副作用的可能性与ω-3组女性相同(RR 1.12,95% CI 0.56至2.27)。
现有证据尚无定论,无法就专门治疗抑郁的针灸、产妇按摩、强光疗法和ω-3脂肪酸用于治疗产前抑郁症提出任何建议。纳入的试验样本量太小且不可推广,无法提出任何建议。